Načítá se...
Neoadjuvant therapy for gastroesophageal adenocarcinoma
Gastric and esophageal adenocarcinomas are one of the main causes of cancer-related death worldwide. While the incidence of gastric adenocarcinoma is decreasing, the incidence of gastroesophageal junction adenocarcinoma is rising rapidly in Western countries. Considering that surgical resection is c...
Uloženo v:
| Vydáno v: | World J Clin Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4896896/ https://ncbi.nlm.nih.gov/pubmed/27298768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v7.i3.284 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|